Organogenesis Holdings Inc. (ORGO) key performance indicators and operating metrics (7 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Net Product Revenue | 36.25M | FY2026-Q1 |
| Net Product Revenue from Advanced Wound Care Products | 29.48M | FY2026-Q1 |
| Net Product Revenue from Surgical and Sports Medicine Products | 6.77M | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 84.2M | FY2025-Q4 |
| Adjusted Net Income (Non-GAAP) | 52.9M | FY2025-Q4 |
| Operating Income (Loss) (Non-GAAP) | 75.9M | FY2025-Q4 |
| Net Revenue from Advanced Wound Care Products | 79.93M | FY2025-Q1 |
Back to ORGO overview · ORGO earnings · ORGO holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.